CB4211, A NOVEL ANALOG OF MOTS-C, IMPROVES MARKERS OF LIVER INJURY AND METABOLISM IN OBESE SUBJECTS WITH NONALCOHOLIC FATTY LIVER DISEASE: A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
HEPATOLOGY(2021)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined